Next Article in Journal
Dilated Cardiomyopathy Associated with Paraquat Herbicide Poisoning
Previous Article in Journal
The Effect of Ranibizumab Loading Treatment on Vision-Related Quality of Life in Diabetic Macular Edema
Review

Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations

1
Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi 111499, United Arab Emirates
2
Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi 111499, United Arab Emirates
3
College of Medicine, University of Sharjah, Sharjah 999041, United Arab Emirates
4
Emirates Oncology Society, Dubai 22107, United Arab Emirates
5
Sheikh Khalifa Specialty Hospital, Ras Alkhaima 999041, United Arab Emirates
6
Rashid Hospital, Dubai 111499, United Arab Emirates
7
American Hospital, Dubai 111499, United Arab Emirates
8
Dubai Hospital, Dubai 111499, United Arab Emirates
9
Zayed Military Hospital, Abu Dhabi 111499, United Arab Emirates
*
Author to whom correspondence should be addressed.
Clin. Pract. 2021, 11(3), 671-678; https://doi.org/10.3390/clinpract11030082
Received: 30 July 2021 / Revised: 6 September 2021 / Accepted: 10 September 2021 / Published: 15 September 2021
In the United Arab Emirates (UAE), lung cancer (LC) was the third leading cause of deaths due to cancer in 2017. Around 80% of the patients in the UAE are diagnosed at a late stage, rendering the treatment less effective in improving survival outcomes. Lack of awareness of disease symptomatology, deficient screening initiatives, misdiagnosis, and delayed referral to the specialist are contributing factors for delayed diagnosis. Effective screening at a primary care setting can be crucial for early diagnosis, referral to specialists, and enhancing patient outcomes. It is important to establish screening and referral guidelines through which each suspected case can be identified and provided timely intervention. Although the international screening and referral pathway framework are comprehensive, several regional barriers need to be addressed before they can be adapted at the national level. A group of LC experts from the UAE deliberated on issues like delayed diagnosis of LC and strategic recommendations for overcoming the challenges. The discussion was based on the review of the published evidence, international and regional guidelines for screening and early diagnosis of LC. Herein, we present a guideline, endorsed by the esteemed panel of experts, for aiding early diagnosis and optimizing the management of LC in the UAE. View Full-Text
Keywords: lung cancer; United Arab Emirates; screening; referral pathway lung cancer; United Arab Emirates; screening; referral pathway
Show Figures

Figure 1

MDPI and ACS Style

Al-Shamsi, H.O.; Jaffar, H.; Mahboub, B.; Khan, F.; Albastaki, U.; Hammad, S.; Zaabi, A.A. Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations. Clin. Pract. 2021, 11, 671-678. https://doi.org/10.3390/clinpract11030082

AMA Style

Al-Shamsi HO, Jaffar H, Mahboub B, Khan F, Albastaki U, Hammad S, Zaabi AA. Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations. Clinics and Practice. 2021; 11(3):671-678. https://doi.org/10.3390/clinpract11030082

Chicago/Turabian Style

Al-Shamsi, Humaid O., Hassan Jaffar, Bassam Mahboub, Faraz Khan, Usama Albastaki, Sayed Hammad, and Ashraf A. Zaabi 2021. "Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations" Clinics and Practice 11, no. 3: 671-678. https://doi.org/10.3390/clinpract11030082

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop